UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Do we need to analyse everything at diagnosis in chronic lymphocytic leukaemia?

British journal of haematology, 2020-05, Vol.189 (4), p.603-604

Gribben, John G.

2020

Volltextzugriff (PDF)

Optimising outcomes for patients with chronic lymphocytic leukaemia on ibrutinib therapy: European recommendations for clinical practice

British journal of haematology, 2018-03, Vol.180 (5), p.666-679

2018

Volltextzugriff (PDF)

Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial

The lancet oncology, 2019-01, Vol.20 (1), p.43-56

2019

Volltextzugriff (PDF)

Stabilization of β-catenin upon B-cell receptor signaling promotes NF-kB target genes transcription in mantle cell lymphoma

Oncogene, 2020-04, Vol.39 (14), p.2934-2947

2020

Volltextzugriff (PDF)

High Throughput Sequencing Analysis of the Immunoglobulin Heavy Chain Gene from Flow-Sorted B Cell Sub-Populations Define the Dynamics of Follicular Lymphoma Clonal Evolution

PloS one, 2015-09, Vol.10 (9), p.e0134833

2015

Volltextzugriff (PDF)

Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug

The Journal of clinical investigation, 2008-07, Vol.118 (7), p.2427-2437

2008

Volltextzugriff (PDF)

The combination of CHK1 inhibitor with G-CSF overrides cytarabine resistance in human acute myeloid leukemia

Nature communications, 2017-11, Vol.8 (1), p.1679-12, Article 1679

2017

Volltextzugriff (PDF)

Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells

The Journal of clinical investigation, 2005-07, Vol.115 (7), p.1797-1805

2005

Volltextzugriff (PDF)

Antigen presenting cell-mediated expansion of human umbilical cord blood yields log-scale expansion of natural killer cells with anti-myeloma activity

PloS one, 2013-10, Vol.8 (10), p.e76781-e76781

2013

Volltextzugriff (PDF)

Obinutuzumab for the treatment of indolent lymphoma

Future oncology (London, England), 2016-08, Vol.12 (15), p.1769-1781

2016

Volltextzugriff (PDF)

Single‐agent ibrutinib versus chemoimmunotherapy regimens for treatment‐naïve patients with chronic lymphocytic leukemia: A cross‐trial comparison of phase 3 studies

American journal of hematology, 2018-11, Vol.93 (11), p.1402-1410

2018

Volltextzugriff (PDF)

Generation of functional CLL-specific cord blood CTL using CD40-ligated CLL APC

PloS one, 2012-12, Vol.7 (12), p.e51390-e51390

2012

Volltextzugriff (PDF)

Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes

Signal transduction and targeted therapy, 2023-02, Vol.8 (1), p.80-80, Article 80

2023

Volltextzugriff (PDF)

The genomic landscape of teenage and young adult T‐cell acute lymphoblastic leukemia

Cancer medicine (Malden, MA), 2021-07, Vol.10 (14), p.4864-4873

2021

Volltextzugriff (PDF)

Chronic Lymphocytic Leukemia: An Update on Biology and Treatment

Current oncology reports, 2011-10, Vol.13 (5), p.379, Article 379

2011

Volltextzugriff (PDF)

Single cell analysis of clonal architecture in acute myeloid leukaemia

Leukemia, 2019-05, Vol.33 (5), p.1113-1123

2019

Volltextzugriff (PDF)

Computational identification of CDR3 sequence archetypes among immunoglobulin sequences in chronic lymphocytic leukemia

Leukemia research, 2009-03, Vol.33 (3), p.368-376

2009

Volltextzugriff (PDF)

Chronic lymphocytic leukaemia

Nature reviews. Disease primers, 2017-01, Vol.3 (1), p.16096, Article 16096

2017

Volltextzugriff (PDF)

Long-term follow-up of reduced-intensity allogeneic stem cell transplantation for chronic lymphocytic leukemia: prognostic model to predict outcome

Leukemia, 2013-02, Vol.27 (2), p.362-369

2013

Volltextzugriff (PDF)

ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)

Annals of oncology, 2013-03, Vol.24 (3), p.561-576

2013

Volltextzugriff (PDF)

SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML

Oncogene, 2023-12, Vol.42 (50), p.3670-3683

2023

Volltextzugriff (PDF)

Frequent evolution of copy number alterations in CLL following first-line treatment with FC(R) is enriched with TP53 alterations: results from the CLL8 trial

Leukemia, 2017-03, Vol.31 (3), p.734-738

2017

Volltextzugriff (PDF)

The European landscape on allogeneic haematopoeietic cell transplantation in Chronic Lymphocytic Leukaemia between 2009 and 2019: a perspective from the Chronic Malignancies Working Party of the EBMT

Bone marrow transplantation (Basingstoke), 2023-06, Vol.58 (6), p.621-624

2023

Volltextzugriff (PDF)

Proteomic and genomic integration identifies kinase and differentiation determinants of kinase inhibitor sensitivity in leukemia cells

Leukemia, 2018-08, Vol.32 (8), p.1818-1822

2018

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Aktive Filter

KollektionPublisher website

KollektionMEDLINE

ThemaLeukemia

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(31)

Sprache

Englisch
(31)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(31)
Science & Technology
(28)
Life Sciences & Biomedicine
(23)
Oncology
(16)
Hematology
(13)
Chronic Lymphocytic Leukemia
(11)
Chemotherapy
(10)
Animals
(9)
Cancer
(9)
Mice
(9)
Patients
(9)
Female
(8)
Mutation
(8)
Kinases
(7)
Acute Myeloid Leukemia
(6)
Leukemia, Lymphocytic, Chronic, B-Cell - Immunology
(6)
Leukemia, Myeloid, Acute - Drug Therapy
(6)
Leukemia, Myeloid, Acute - Genetics
(6)
Lymphoma
(6)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Do we need to analyse everything at diagnosis in chronic lymphocytic leukaemia?

Optimising outcomes for patients with chronic lymphocytic leukaemia on ibrutinib therapy: European recommendations for clinical practice

Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial

Stabilization of β-catenin upon B-cell receptor signaling promotes NF-kB target genes transcription in mantle cell lymphoma

High Throughput Sequencing Analysis of the Immunoglobulin Heavy Chain Gene from Flow-Sorted B Cell Sub-Populations Define the Dynamics of Follicular Lymphoma Clonal Evolution

Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug

The combination of CHK1 inhibitor with G-CSF overrides cytarabine resistance in human acute myeloid leukemia

Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells

Antigen presenting cell-mediated expansion of human umbilical cord blood yields log-scale expansion of natural killer cells with anti-myeloma activity

Obinutuzumab for the treatment of indolent lymphoma

Multi-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia

Single‐agent ibrutinib versus chemoimmunotherapy regimens for treatment‐naïve patients with chronic lymphocytic leukemia: A cross‐trial comparison of phase 3 studies

Generation of functional CLL-specific cord blood CTL using CD40-ligated CLL APC

Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes

The genomic landscape of teenage and young adult T‐cell acute lymphoblastic leukemia

Chronic Lymphocytic Leukemia: An Update on Biology and Treatment

Single cell analysis of clonal architecture in acute myeloid leukaemia

Computational identification of CDR3 sequence archetypes among immunoglobulin sequences in chronic lymphocytic leukemia

Chronic lymphocytic leukaemia

Long-term follow-up of reduced-intensity allogeneic stem cell transplantation for chronic lymphocytic leukemia: prognostic model to predict outcome

ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)

SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML

Frequent evolution of copy number alterations in CLL following first-line treatment with FC(R) is enriched with TP53 alterations: results from the CLL8 trial

The European landscape on allogeneic haematopoeietic cell transplantation in Chronic Lymphocytic Leukaemia between 2009 and 2019: a perspective from the Chronic Malignancies Working Party of the EBMT

Proteomic and genomic integration identifies kinase and differentiation determinants of kinase inhibitor sensitivity in leukemia cells

Aktive Filter

Suchergebnisse filtern